Darzalex Daratumumab 1800mg injection About
- Active ingredient: Daratumumab, a monoclonal antibody.
- Target: Binds to the CD38 protein found on abnormal white blood cells.
- Action: Signals your immune system to destroy the cancer cells
Precision Monoclonal Antibody TherapyDarzalex Daratumumab delivers a focused treatment for multiple myeloma by utilizing a monoclonal antibody that binds specifically to the CD38 protein on myeloma cells. This mechanism initiates a targeted immune response, helping your body fight off abnormal white blood cells efficiently and effectively.
Convenient Single-Dose Vial PackagingDesigned for ease of use in clinical settings, Darzalex comes in a single 15 mL vial containing the prescribed dose for one subcutaneous injection. Its ready-to-use packaging ensures accurate dosing and reduces the risk of contamination or dosing errors.
Simple Subcutaneous AdministrationDarzalex is administered via subcutaneous injection, typically taking between 3 to 5 minutes. This less invasive route offers benefits over intravenous formulations, potentially leading to shorter clinic visits and improved patient comfort during treatment.
FAQ's of Darzalex Daratumumab 1800mg injection:
Q: How is Darzalex Daratumumab 1800mg injection administered?
A: Darzalex Daratumumab is administered as a single subcutaneous injection into the abdominal area by a healthcare professional. The recommended dose (15 mL) should be given slowly over 3 to 5 minutes.
Q: What is the primary benefit of Darzalex in treating multiple myeloma?
A: The main advantage of Darzalex is its ability to specifically target the CD38 protein on abnormal white blood cells, enabling your immune system to recognize and destroy multiple myeloma cells, thus helping manage the disease.
Q: When should Darzalex be used for multiple myeloma?
A: Darzalex is prescribed for adults diagnosed with multiple myeloma, usually as part of a combination therapy or in cases where other treatments are insufficient. The exact timing is determined by your oncologist based on your individual treatment plan.
Q: Where should unused portions of the vial be disposed?
A: Any unused portion of Darzalex should be discarded immediately after the single-dose injection, according to local regulations and your healthcare provider's instructions. Do not attempt to store or reuse any leftover medication.
Q: What ingredients are present in the Darzalex injection?
A: Each vial contains 1,800 mg daratumumab (monoclonal antibody) and 30,000 Units hyaluronidase-fihj, formulated to enhance absorption and efficacy when administered subcutaneously.
Q: Is a prescription required to obtain Darzalex Daratumumab 1800mg injection?
A: Yes, Darzalex is a prescription-only medication and must be administered by a qualified healthcare professional under medical supervision.
Q: How should Darzalex be stored before administration?
A: Store the vial according to the manufacturer's instructions, typically in a refrigerator. Do not freeze or expose it to light, and always check with your provider for specific storage requirements.